Labeler
NorthStar RxLLC NDC Codes
NorthStar RxLLC lists 301 finished drug products in the FDA NDC Directory under NDC labeler codes 16714, 72603.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Levothyroxine Sodium, Atomoxetine, Pregabalin, Dasatinib, Atorvastatin calcium, Doxepin Hydrochloride, Nebivolol, lurasidone hydrochloride, Lidocaine hydrochloride, Everolimus, Olmesartan medoxomil, Sacubitril and Valsartan, Midodrine Hydrochloride, Venlafaxine Hydrochloride, Irbesartan
- Active ingredients
- Levothyroxine sodium, Atomoxetine hydrochloride, Pregabalin, Dasatinib, Atorvastatin calcium trihydrate, Doxepin hydrochloride, Nebivolol hydrochloride, Lurasidone hydrochloride, Lidocaine hydrochloride anhydrous, Everolimus, Olmesartan medoxomil, Sacubitril
- NDC labeler codes
- 16714, 72603
- Strengths (from the 100 most recently listed products)
- Atorvastatin calcium trihydrate 10 mg/1; Lidocaine hydrochloride anhydrous 10 mg/mL; Lidocaine hydrochloride anhydrous 20 mg/mL; Bupivacaine hydrochloride 7.5 mg/mL; Ticagrelor 60 mg/1; Ticagrelor 90 mg/1; Olmesartan medoxomil 5 mg/1; Olmesartan medoxomil 20 mg/1; Olmesartan medoxomil 40 mg/1; Sacubitril 24 mg/1; Valsartan 26 mg/1; Sacubitril 49 mg/1; Valsartan 51 mg/1; Sacubitril 97 mg/1; Valsartan 103 mg/1; Midodrine hydrochloride 2.5 mg/1; Midodrine hydrochloride 5 mg/1; Midodrine hydrochloride 10 mg/1; Rivaroxaban 2.5 mg/1; Venlafaxine hydrochloride 37.5 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Capsule, Injection, Solution, Capsule, Extended release, Ointment, Solution, Suppository, Powder, For suspension, Tablet, Delayed release, Solution/ drops, Injection, Powder, Lyophilized, For solution
- Routes
- Oral, Infiltration, Perineural, Topical, Epidural, Retrobulbar, Rectal, Ophthalmic, Intravenous, Subcutaneous
- Drug classes (FDA established)
- Angiotensin 2 Receptor Blocker, l-Thyroxine, Kinase Inhibitor, Norepinephrine Reuptake Inhibitor, HMG-CoA Reductase Inhibitor, Amide Local Anesthetic, beta-Adrenergic Blocker, Tricyclic Antidepressant, Atypical Antipsychotic, Antiarrhythmic, mTOR Inhibitor Immunosuppressant, Neprilysin Inhibitor, alpha-Adrenergic Agonist, Serotonin and Norepinephrine Reuptake Inhibitor, Corticosteroid, Glinide, P2Y12 Platelet Inhibitor, Peroxisome Proliferator Receptor alpha Agonist, Osmotic Laxative, Factor Xa Inhibitor, Nonsteroidal Anti-inflammatory Drug, Direct Thrombin Inhibitor, Calculi Dissolution Agent, Phosphate Binder, Nucleoside Metabolic Inhibitor, Aminosalicylate, Proteasome Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 147 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Heparin Sodium | Heparin sodium 1000 [USP'U]/mL | InjectionIntravenous, Subcutaneous | 72603-179 | 72603-0179-25 | — |
| Leuprolide Acetate | — | KitSubcutaneous | 72603-344 | 72603-0344-01 | — |
| Glycopyrrolate | Glycopyrrolate 1 mg/5mL | SolutionOral | 72603-240 | 72603-0240-01 | — |
| Escitalopram Oxalate | Escitalopram oxalate 5 mg/1 | Tablet, Film coatedOral | 72603-149 | 72603-0149-01 | — |
| Escitalopram Oxalate | Escitalopram oxalate 10 mg/21 | Tablet, Film coatedOral | 72603-150 | 72603-0150-01 | — |
| Escitalopram Oxalate | Escitalopram oxalate 20 mg/21 | Tablet, Film coatedOral | 72603-151 | 72603-0151-01 | — |
| Pantoprazole | Pantoprazole sodium 20 mg/1 | Tablet, Delayed releaseOral | 72603-177 | 72603-0177-01 | — |
| Pantoprazole | Pantoprazole sodium 40 mg/1 | Tablet, Delayed releaseOral | 72603-178 | 72603-0178-01 | — |
| nitrofurantoin macrocrystals | Nitrofurantoin 25 mg/1 | CapsuleOral | 72603-182 | 72603-0182-01 | — |
| nitrofurantoin macrocrystals | Nitrofurantoin 50 mg/1 | CapsuleOral | 72603-183 | 72603-0183-01 | — |
| nitrofurantoin macrocrystals | Nitrofurantoin 100 mg/1 | CapsuleOral | 72603-184 | 72603-0184-01 | — |
| ofloxacinofloxacin otic | Ofloxacin 3 mg/mL | SolutionAuricular (Otic) | 72603-186 | 72603-0186-0172603-0186-02 | — |
| sapropterin dihydrochloride | Sapropterin dihydrochloride 100 mg/1 | TabletOral | 72603-191 | 72603-0191-01 | — |
| ofloxacin | Ofloxacin 3 mg/mL | Solution/ dropsOphthalmic | 72603-192 | 72603-0192-0172603-0192-02 | — |
| Sapropterin dihydrochloride | Sapropterin dihydrochloride 100 mg/1 | Powder, For solutionOral | 72603-193 | 72603-0193-30 | — |
| Sapropterin dihydrochloride | Sapropterin dihydrochloride 500 mg/1 | Powder, For solutionOral | 72603-194 | 72603-0194-30 | — |
| Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin monohydrate 75 mg/1; Nitrofurantoin 25 mg/1 | CapsuleOral | 72603-196 | 72603-0196-01 | — |
| Haloperidol Decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | 72603-230 | 72603-0230-01 | — |
| Brimonidine tartrate and Timolol maleate | Brimonidine tartrate 2 mg/mL; Timolol maleate 5 mg/mL | Solution/ dropsOphthalmic | 72603-931 | 72603-0931-0572603-0931-10 | — |
| Olanzapine | Olanzapine 10 mg/2mL | Injection, Powder, For solutionIntramuscular | 72603-181 | 72603-0181-01 | — |
| Timolol Maleate Ophthalmic Gel Forming Solution 0.25% | Timolol maleate 2.5 mg/mL | Solution/ dropsOphthalmic | 72603-162 | 72603-0162-01 | — |
| Timolol Maleate Ophthalmic Gel Forming Solution 0.5% | Timolol maleate 5 mg/mL | Solution/ dropsOphthalmic | 72603-163 | 72603-0163-01 | — |
| Olanzapine | Olanzapine 2.5 mg/1 | Tablet, Film coatedOral | 72603-154 | 72603-0154-0172603-0154-0272603-0154-03 | — |
| Olanzapine | Olanzapine 7.5 mg/1 | Tablet, Film coatedOral | 72603-156 | 72603-0156-01 | — |
| Olanzapine | Olanzapine 10 mg/1 | Tablet, Film coatedOral | 72603-157 | 72603-0157-0172603-0157-0272603-0157-03 | — |
| Olanzapine | Olanzapine 20 mg/1 | Tablet, Film coatedOral | 72603-159 | 72603-0159-0172603-0159-0272603-0159-03 | — |
| Daptomycin | Daptomycin 350 mg/7mL | Injection, Powder, Lyophilized, For solutionIntravenous | 72603-147 | 72603-0147-01 | — |
| Daptomycin | Daptomycin 500 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 72603-152 | 72603-0152-01 | — |
| Posaconazole | Posaconazole 100 mg/1 | Tablet, Delayed releaseOral | 16714-535 | 16714-0535-01 | — |
| Enoxaparin Sodium | Enoxaparin sodium 60 mg/.6mL | Injection, SolutionSubcutaneous | 72603-185 | 72603-0185-10 | — |
| Enoxaparin Sodium | Enoxaparin sodium 80 mg/.8mL | Injection, SolutionSubcutaneous | 72603-195 | 72603-0195-10 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | Injection, SolutionSubcutaneous | 72603-205 | 72603-0205-10 | — |
| Enoxaparin Sodium | Enoxaparin sodium 120 mg/.8mL | Injection, SolutionSubcutaneous | 72603-215 | 72603-0215-10 | — |
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | Injection, SolutionSubcutaneous | 72603-225 | 72603-0225-10 | — |
| Enoxaparin Sodium | Enoxaparin sodium 30 mg/.3mL | Injection, SolutionSubcutaneous | 72603-165 | 72603-0165-10 | — |
| Enoxaparin Sodium | Enoxaparin sodium 40 mg/.4mL | Injection, SolutionSubcutaneous | 72603-175 | 72603-0175-10 | — |
| Dofetilide | Dofetilide .125 mg/1 | CapsuleOral | 72603-130 | 72603-0130-01 | — |
| Dofetilide | Dofetilide .25 mg/1 | CapsuleOral | 72603-131 | 72603-0131-01 | — |
| Dofetilide | Dofetilide .5 mg/1 | CapsuleOral | 72603-132 | 72603-0132-01 | — |
| Fosaprepitantfosaprepitant dimeglumine | Fosaprepitant dimeglumine 150 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 16714-248 | 16714-0248-01 | — |
| Topiramate | Topiramate 25 mg/1 | Capsule, Extended releaseOral | 72603-120 | 72603-0120-01 | — |
| Topiramate | Topiramate 50 mg/1 | Capsule, Extended releaseOral | 72603-121 | 72603-0121-01 | — |
| Topiramate | Topiramate 100 mg/1 | Capsule, Extended releaseOral | 72603-122 | 72603-0122-01 | — |
| Topiramate | Topiramate 150 mg/1 | Capsule, Extended releaseOral | 72603-123 | 72603-0123-01 | — |
| Topiramate | Topiramate 200 mg/1 | Capsule, Extended releaseOral | 72603-124 | 72603-0124-01 | — |
| Memantine | Memantine hydrochloride 5 mg/1 | TabletOral | 72603-118 | 72603-0118-01 | — |
| Memantine | Memantine hydrochloride 10 mg/1 | TabletOral | 72603-119 | 72603-0119-0172603-0119-02 | — |
| Pioglitazone | Pioglitazone hydrochloride 15 mg/1 | TabletOral | 16714-645 | 16714-0645-0116714-0645-0216714-0645-03 | — |
| Pioglitazone | Pioglitazone hydrochloride 30 mg/1 | TabletOral | 16714-646 | 16714-0646-0116714-0646-0216714-0646-03 | — |
| Pioglitazone | Pioglitazone hydrochloride 45 mg/1 | TabletOral | 16714-647 | 16714-0647-0116714-0647-0216714-0647-03 | — |
NorthStar RxLLC: common questions
- What is NorthStar RxLLC's NDC labeler code?
- 16714, 72603. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for NorthStar RxLLC?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.